AU2962200A - Use of agonists or antagonists of mip-3a in therapy - Google Patents

Use of agonists or antagonists of mip-3a in therapy

Info

Publication number
AU2962200A
AU2962200A AU29622/00A AU2962200A AU2962200A AU 2962200 A AU2962200 A AU 2962200A AU 29622/00 A AU29622/00 A AU 29622/00A AU 2962200 A AU2962200 A AU 2962200A AU 2962200 A AU2962200 A AU 2962200A
Authority
AU
Australia
Prior art keywords
mip
agonists
antagonists
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29622/00A
Inventor
Christophe Caux
Marie-Caroline Dieu-Nosjean
Bernhard Homey
Elizabeth R. Oldham
Albert Zlotnik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU2962200A publication Critical patent/AU2962200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/195—Chemokines, e.g. RANTES
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
AU29622/00A 1999-02-03 2000-02-02 Use of agonists or antagonists of mip-3a in therapy Abandoned AU2962200A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24428199A 1999-02-03 1999-02-03
US09244281 1999-02-03
PCT/US2000/000511 WO2000046248A1 (en) 1999-02-03 2000-02-02 Use of agonists or antagonists of mip-3a in therapy

Publications (1)

Publication Number Publication Date
AU2962200A true AU2962200A (en) 2000-08-25

Family

ID=22922114

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29622/00A Abandoned AU2962200A (en) 1999-02-03 2000-02-02 Use of agonists or antagonists of mip-3a in therapy

Country Status (5)

Country Link
EP (1) EP1149113A1 (en)
JP (1) JP2002540068A (en)
AU (1) AU2962200A (en)
CA (1) CA2362091A1 (en)
WO (1) WO2000046248A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1214090A2 (en) * 1999-09-08 2002-06-19 Schering Corporation Novel uses of mammalian ccr6 receptors and related reagents
EP2261256A3 (en) * 1999-11-24 2011-03-02 Schering Corporation Methods of inhibiting metastasis
US6949243B1 (en) 1999-11-24 2005-09-27 Schering Corporation Methods of inhibiting metastasis
WO2003024404A2 (en) * 2001-09-20 2003-03-27 Schering Corporation Chemokines as adjuvants of immune response
ATE518884T1 (en) * 2002-05-01 2011-08-15 Human Genome Sciences Inc ANTIBODIES SPECIFICALLY BINDING TO CHEMOKIN BETA-4
WO2004078208A1 (en) * 2003-03-04 2004-09-16 Takeda Pharmaceutical Company Limited MEDICINAL USE OF MIP-3α INHIBITOR AND METHOD OF SCREENING BRAIN/NERVE CELL PROTECTIVE AGENT
EP1605966A1 (en) * 2003-03-24 2005-12-21 TAP Pharmaceutical Products, Inc. Use of chemokine receptor agonists for stem cell transplantation
US20090304704A1 (en) * 2006-05-03 2009-12-10 Geisinger Clinic Methods for diagnosing and predicting non-alcoholic steatohepatitis (nash)
UA114077C2 (en) 2010-11-19 2017-04-25 NEUTRALIZING ANTIBODY AGAINST CCL20

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5504003A (en) * 1994-03-08 1996-04-02 Human Genome Sciences, Inc. Macrophage inflammatory protein-3 and -4
JP2000514295A (en) * 1996-07-05 2000-10-31 シェーリング コーポレイション Mammalian chemokine reagent
MXPA00003885A (en) * 1997-10-22 2004-04-23 Inst Genetics Llc Chimeric polypeptides containing chemokine domains.
AU5459599A (en) * 1998-08-17 2000-03-06 Schering Corporation Regulation of dendritic cell trafficking

Also Published As

Publication number Publication date
JP2002540068A (en) 2002-11-26
EP1149113A1 (en) 2001-10-31
CA2362091A1 (en) 2000-08-10
WO2000046248A1 (en) 2000-08-10

Similar Documents

Publication Publication Date Title
AU1293101A (en) Ep4 receptor selective agonists in the treatment of osteoporosis
AU2001264313A1 (en) Pyrazolopyridine compounds and use thereof as drugs
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU2001244355A1 (en) Heterobiarylsulphonamides and their use as pde 7 inhibitors
GB0004167D0 (en) 1-piperidinyl-propan-2-ol derivatives and their use as therapeutic agents
PL352330A1 (en) Derivatives of pyridopyranoazepine, making of same and use of same in therapy
AU2002247208A1 (en) Selective pde3b inhibitors and use of the same in therapy
AU1164601A (en) Therapeutic use and formulation
PL349769A1 (en) New amidinobenzylamine derivatives and their use as thrombin inhibitors
AU2962200A (en) Use of agonists or antagonists of mip-3a in therapy
AU2912600A (en) Substituted bicyclic heterocycles and the use thereof as thrombin inhibitors
AU2001248971A1 (en) Use of npy y1 receptor agonists in the treatment of pain conditions
AU4129800A (en) Bis-benzazoles and their use as antineoplastic agents
AU2002302735A1 (en) 3-aminoalkyl-2-aryl-indole derivatives and their use as gnrh antagonists
AU3979700A (en) Use of osseo-promotive membranes in orthopaedics
AU2399601A (en) Novel tachykinin-like polypeptides and use thereof
AU2669201A (en) Taccalonolides and their use
EP1324763A4 (en) Stat3 agonists and antagonists and therapeutic uses thereof
AU2021801A (en) Ultrasonic marker for use in surgery
AU5974100A (en) 6-carboxyphenyldihydropyridazinone derivatives and use thereof
AU4021700A (en) Methods of use of beta1-integrin inhibitors
AU2002328173A1 (en) Omoxin agonists and antagonists for use in the treatment of metabolic disorders
AU6150400A (en) Tetrahydroquinolinyl-6-methyldihydrothiadiazinone derivatives and use thereof
AU3808800A (en) Compounds for use in therapy
AU2002334251A1 (en) Mifaxin agonists and antagonists for use in the treatment of metabolic

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase